16 March 2015
is one of the world’s leading private equity and
investment advisory firms.
Founded in 1981, the CVC Group today employs
some 300 people throughout Europe, Asia and the US.
The CVC team's local knowledge and extensive contacts
underpin a proven track record of
over 30 years of investment success.
DETAILS
Royal DSM, and
today announced a partnership for DSM’s activities in
Polymer Intermediates (Caprolactam and Acrylonitrile) and
Composite Resins through
the formation of a new company,
provisionally called
NewCo.
For DSM, this proposed transaction
is a logical step in the execution of its strategy as
Polymer Intermediates (caprolactam, acrylonitrile) and
Composite Resins
no longer fit with its more resilient portfolio
in Nutrition and Performance Materials.
The partnership with CVC allows DSM to further
reduce the cyclicality of its portfolio,
secure a long-term competitive supply position of caprolactam
for DSM Engineering Plastics and
fully focus on the Nutrition, Performance Materials and
Innovation activities
complemented by accelerated actions
to improve efficiencies and reduce costs.
WWW.CHEMWINFO.COM BY KHUN PHICHAI
